Innovation hangout for academia and industry

Welcome to this meeting place where we want to inspire researchers and students, give them self-confidence and knowledge about the innovation process, help them build networks, and facilitate collaboration between academia and industry. This hangout is a collaboration with Oslo Cancer Cluster and Oslo Cancer Cluster Incubator.

People talking and networking. Signs saying innovation hangout – a meeting place for academia and industry and tonight, talks, matchmaking, mingling.

For researchers and students at the University of Oslo, researchers at Oslo University Hospital (OUS) and Akershus University Hospital (Ahus), members of Oslo Cancer Cluster, Oslo Cancer Cluster Incubator, The Life Science Cluster, Health2B, Norway Health Tech, LMI, Aleap, the Oslo Science Park community and Oslo Science City partners. Free of charge, but you have to sign up.

The programme will be out about one month before the event.

You may already sign up up in this webform.

Registration opens at 4:30 PM, programme starts at 5:00 PM

Programme

Inspirational talks

Erik SkullerudThe rocky road of biotech commercialization

Erik Skullerud, M.Sc., Founder, Insider Group

 

 

 

Ester SlarskyInvestor perspective on the “rocky road” for biotechs

Ester Sklarsky, M.Sc., Principal, Sound Bioventures

 

 

 

More information about the speakers and their talks TBA

Role model talk 

Richard Crispin, PhD, CMC Development Manager, ARTBIO

More about the speaker, his talk and ARTBIO

Richard has a background in chemistry and biomedical sciences, with experience in drug discovery, drug development, cell pharmacology and organic chemistry. He has a PhD in cancer research from The University of Edinburgh.

Now he is a Chemistry Manufacturing and Controls (CMC) Manager i ARTBIO. He will talk about is career path with experience from both academia and industry. 

ARTBIO works on Radioligand therapy (RLT). According to their website this is a promising new approach for cancer treatment: "While beta radioligand therapies are currently more common in clinical practice, alpha radioligand therapies offer potentially significantly better efficacy and safety to patients". ARTBIO works on understanding both cancer biology, and the infrastructure needed to effectively design, manufacture, and distribute their therapies.

Meet the companies

 

Logo Nucleate
Nucleate
Norway
 

More companies TBA.

Networking with companies 

Food and beverages, and mingling

About the innovation hangouts

This is an informal meeting place where students and researchers from the University of Oslo (UiO) can interact with actors from the public sector, hospitals, companies, mentors, business clusters and incubators within UiO's innovation ecosystem. We will provide inspirational talks, talks from role models, matchmaking, food and beverages, and mingling.

The overall goal of the UiO Growth House is to strengthen the innovation culture at UiO to put more knowledge from research to use. With this meeting place, we want to inspire researchers and students, give them self-confidence and knowledge about the innovation process, help them build networks, and facilitate collaboration between academia and industry.

The UiO Growth House established the innovation hangouts in collaboration with clusters in 2022. The events are arranged quarterly in the afternoon/evening.

Questions?

Please contact the UiO Growth House, Norunn K. Torheim, Head of communications and public and external relations, at norunnt@uio.no

Published Jan. 6, 2025 4:28 PM - Last modified Feb. 19, 2025 4:09 PM